eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-PBYI-Puma Biotechnology Inc

Puma Biotechnology Inc PBYI

$5.040.07(1.41%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Puma Biotechnology Inc
Today
Create an eToro account to buy PBYI stock on a secure, user-friendly, multi-asset trading platform.
Buy Puma Biotechnology Inc
Buy Puma Biotechnology Inc
Puma Biotechnology Inc PBYI
Buy PBYI
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Hold
Price Target
4.00
Based on analysts who covered PBYI

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Puma Biotechnology Inc News

About Puma Biotechnology Inc
Puma Biotechnology Inc. is an American biopharmaceutical company, which has its corporate headquarters in Los Angeles, California, and is incorporated in Delaware. The company is engaged in the development and commercialisation of a range of solutions aimed primarily at cancer patients across the United States and throughout the world. The firm was founded in 2010.

The firm is predominantly focused on acquiring and developing innovative biopharmaceutical products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing, and then seeks to further develop those drug candidates for commercial use.

The firm’s has a strong focus on breast cancers, and current drug candidates include PB272 for the adjuvant treatment of adult patients with early stage HER2-overamplified breast cancer, PB272 for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer and PB272 for HER2 mutation-positive solid tumours. The company’s common stock began trading in 2012. The firm is now listed on the NASDAQ where it trades under the stock ticker PBYI.

Monitor the Puma Biotechnology Inc. share price by adding it to your eToro watchlist, to get instant news and updates on PBYI stock value changes.
VIEW MORE   

PBYI Stock Price Chart

‎52.89‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Puma Biotechnology Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Puma Biotechnology Inc share price today is $5.04, reflecting a ‎1.41‎% change over the last 24 hours and ‎-4.01‎% over the past week. The current market capitalization of PBYI is $253.87M with an average volume in the last three months of 544505.69. The stock has a P/E ratio of 5.14 and a dividend yield of 0%. With the stock’s beta sitting at 0.94
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$253.87M
Day’s Range
i
Shows the high and low prices of the day.
$4.9 - $5.02
52W Range
i
Shows the high and low prices of the last year.
$2.2 - $7.11
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
544505.69
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
5.14
Revenue
i
The total income generated by this company’s goods and services last year.
$238.06M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
$0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$5.04
EPS
i
A company’s total earnings divided by the number of shares it has issued.
$0.98
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.94
What Is Puma Biotechnology Inc?
Puma Biotechnology Inc. is an American biopharmaceutical company, which has its corporate headquarters in Los Angeles, California, and is incorporated in Delaware. The company is engaged in the development and commercialisation of a range of solutions aimed primarily at cancer patients across the United States and throughout the world. The firm was founded in 2010.

The firm is predominantly focused on acquiring and developing innovative biopharmaceutical products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing, and then seeks to further develop those drug candidates for commercial use.

The firm’s has a strong focus on breast cancers, and current drug candidates include PB272 for the adjuvant treatment of adult patients with early stage HER2-overamplified breast cancer, PB272 for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer and PB272 for HER2 mutation-positive solid tumours. The company’s common stock began trading in 2012. The firm is now listed on the NASDAQ where it trades under the stock ticker PBYI.

Monitor the Puma Biotechnology Inc. share price by adding it to your eToro watchlist, to get instant news and updates on PBYI stock value changes.
Buy PBYI

How can I buy Puma Biotechnology Inc stocks?

To purchase Puma Biotechnology Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Puma Biotechnology Inc (PBYI) page and place an order to buy Puma Biotechnology Inc.
Buy PBYI
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Puma Biotechnology Inc
Invest in Puma Biotechnology Inc
Today
Create an eToro account to buy PBYI stock on a secure, user-friendly, multi-asset trading platform.
Buy PBYI

FAQ

The current price of PBYI is $5.04.
The average price target for Puma Biotechnology Inc is $4.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Puma Biotechnology Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Puma Biotechnology Inc is $253.87M
Based on 1 analysts offering recommendations for PBYI in the last 3 months, the overall consensus is Hold.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top